Microwave ablation versus sorafenib for intermediate-Stage Hepatocellular carcinoma with transcatheter arterial chemoembolization refractoriness: a propensity score matching analysis

Microwave ablation versus sorafenib for intermediate-Stage Hepatocellular carcinoma with transcatheter arterial chemoembolization refractoriness: a propensity score matching analysis

Purpose To compared the benefits of sorafenib with microwave ablation (MWA) in intermediate-stage hepatocellular carcinoma (HCC) patients with tumor size ≤7 cm and tumor number ≤5 after Transcatheter Arterial Chemoembolization (TACE) failure. Methods A retrospective, single-center study was conducte...

Full description

Bibliographic Details
Main Authors: Shuanggang Chen, Mengting Shi, Lujun Shen, Han Qi, Weiqi Wan, Fei Cao, Lin Xie, Ying Wu, Guanjian Chen, Jinqing Mo, Guolian Zhu, Dongdong Ye, Yinqi Zhang, Ziqing Feng, Li Xu, Weijun Fan
Format: Article
Language:English
Published: Taylor & Francis Group 2020-01-01
Series:International Journal of Hyperthermia
Subjects:
chemoembolization therapeutic
treatment failure
ablation techniques
sorafenib
hepatocellular carcinoma
Online Access:http://dx.doi.org/10.1080/02656736.2020.1752400

Internet

http://dx.doi.org/10.1080/02656736.2020.1752400

Similar Items